Oncogene Journal
@oncogenejournal
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research.
ID: 1022429676948664320
http://nature.com/onc 26-07-2018 10:33:25
977 Tweet
2,2K Takipçi
2,2K Takip Edilen
Combined use of farnesyltransferase inhibitors and MEK inhibition is a promising strategy for HRAS-mutant tumours. 🔎nature.com/articles/s4138… Aradhya Nigam, MD Walid Chatila Alan Ho Niki Schultz